2000
DOI: 10.1016/s0002-9394(00)00710-8
|View full text |Cite
|
Sign up to set email alerts
|

Episcleritis and scleritis: clinical features and treatment results

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

8
201
1
25

Year Published

2003
2003
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 324 publications
(235 citation statements)
references
References 16 publications
8
201
1
25
Order By: Relevance
“…Most patients have intermittent bouts of moderate or severe inflammation at intervals of 1–3 months, lasting 7–10 days, and occurring much more commonly during the spring and autumn than in the summer or winter [5]. The nodular type tends to be more recurrent and painful [4].…”
Section: Pathophysiologymentioning
confidence: 99%
See 1 more Smart Citation
“…Most patients have intermittent bouts of moderate or severe inflammation at intervals of 1–3 months, lasting 7–10 days, and occurring much more commonly during the spring and autumn than in the summer or winter [5]. The nodular type tends to be more recurrent and painful [4].…”
Section: Pathophysiologymentioning
confidence: 99%
“…Bilateral involvement suggests underlying systemic disease [5]. Other symptoms of underlying conditions might be helpful in the diagnosis, e.g.…”
Section: Clinical Presentationmentioning
confidence: 99%
“…10 Scleritis is a severe and destructive ocular process, with nearly 60% of patients developing an ocular complication. 12 The presence of scleritis in HZO should alert the clinician to institute intensive topical steroids early. Failure of response to topical treatment requires more aggressive medical management, especially in the presence of necrotizing scleritis, in the hope of preventing such a devastating complication as scleromalacia.…”
Section: Commentmentioning
confidence: 99%
“…The majority of patients with necrotizing scleritis require immunosuppressive treatment. 12 Control of intraocular pressure alone is probably not sufficient to prevent complications such as optic atrophy and extensive visual field loss in zoster iritis. Early institution of steroids, despite the presence of contraindications for their use such as a corneal epithelial defect, should probably be considered even in the presence of mild uveitis.…”
Section: Commentmentioning
confidence: 99%
“…Porém, a artrite reumatóide é descrita como sendo a associação mais comum. Outras vasculites sistêmicas como granulomatose de Wegener também podem ser uma causa (7,8) .O tratamento depende do diagnóstico correto e, em casos mais graves e não responsivos ao tratamento convencional com drogas anti-inflamatórias, pode ser necessário o uso de drogas imunossupressoras para o controle do quadro ocular (9,10) .Uma abordagem multidisciplinar desses casos, muitas vezes, é necessária. Sendo uma avaliação clínica geral e uma investigação laboratorial precoce de extrema importância.…”
unclassified